# Neeraj Agarwal

Source: https://onco.cc/people/neeraj-agarwal/  
OnCo record `neeraj-agarwal` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

GU oncologist who led TALAPRO-2 and other trials combining PARP inhibitors with hormone therapy.

## Summary

Neeraj Agarwal is SWOG Executive Officer for Genitourinary and Early Therapeutics and Professor of Medicine at the Huntsman Cancer Institute, University of Utah. A medical oncologist specialising in prostate and kidney cancer and targeted therapy, he was principal investigator of TALAPRO-2, the trial of talazoparib plus enzalutamide, and of CONTACT-03. His papers report the TALAPRO-2 randomised, placebo-controlled phase 3 trial in first-line metastatic castration-resistant prostate cancer in the Lancet and the design of CONTACT-02, a phase III study of cabozantinib plus atezolizumab versus a second novel hormone therapy in the same disease. He directs genitourinary oncology at Huntsman and works on PARP and the androgen receptor in prostate and renal cell carcinoma.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: SWOG Executive Officer, Genitourinary and Early Therapeutics; Professor of Medicine, Huntsman Cancer Institute, University of Utah
- Specialisms: Prostate cancer; Kidney cancer; Targeted therapy

## Sources

- SWOG leadership: https://www.swog.org/about/leadership
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Agarwal%20N%5BAuthor%5D
- Google Scholar: https://scholar.google.com/scholar?q=Neeraj%20Agarwal

## Connected records

- cancers: [Prostate cancer](https://onco.cc/cancers/prostate/), [Renal cell carcinoma](https://onco.cc/cancers/rcc/)
- targets: [Androgen receptor](https://onco.cc/targets/androgen-receptor/), [PARP](https://onco.cc/targets/parp/)
- drugs: [Talazoparib](https://onco.cc/drugs/talazoparib/)
- companies: [SWOG Cancer Research Network](https://onco.cc/companies/swog/)
- trials: [CONTACT-03](https://onco.cc/trials/contact-03/), [TALAPRO-2](https://onco.cc/trials/talapro-2/)
- journals: [Future oncology](https://onco.cc/journals/future-oncology/)
- institutions: [Huntsman Cancer Institute, University of Utah](https://onco.cc/institutions/huntsman/)

---
JSON: https://onco.cc/api/v1/entities/neeraj-agarwal.json